Concepedia

Author

Theodore Darkow

Health Economics and Outcomes Research (United Kingdom)

Also Known As

T Darkow, T. Darkow, Theodore Darkow, Theodore E Darkow, Theodore E. Darkow

30

Publications

804

Citations

13

H-Index

29

Concepts

All Affiliations

Health Economics and Outcomes Research (United Kingdom)Optum (United States)University of KentuckyHealth Outcomes Solutions (United States)AstraZeneca (United States)
TD

About

Theodore Darkow is an author at Health Economics and Outcomes Research (United Kingdom) specializing in health services research, public health, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

289

2

Public Health

3

3

317

3

Health Sciences

2

2

50

4

Diabetes

1

1

39

5

Global Health

1

1

39

Theodore Darkow

×

15

Publications

786

Citations

13

H-Index

YearCitations

Treatment Interruptions and Non-Adherence with Imatinib and Associated Healthcare Costs

Theodore Darkow, Henry J. Henk, Simu K. Thomas,

PharmacoEconomics

2007

266

Costs Associated with the Management of Overactive Bladder and Related Comorbidities

Theodore Darkow, Christina L. Fontes, Todd Williamson

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

2005

99

Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system

Theodore Darkow, Ann Vanderplas, Kim H. Lew,

Current Medical Research and Opinion

2005

58

Incidence and Costs of Cervical Intraepithelial Neoplasia in a US Commercially Insured Population

Henry J. Henk, Ralph P. Insinga, Puneet K. Singhal,

Journal of Lower Genital Tract Disease

2009

56

Impact of Antiemetic Selection on Postoperative Nausea and Vomiting and Patient Satisfaction

Theodore Darkow, Mary Lea Gora‐Harper, Daniel T. Goulson,

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy

2001

49

Adherence to a Fixed-Dose Combination of Rosiglitazone/Glimepiride in Subjects Switching from Monotherapy or Dual Therapy with a Thiazolidinedione and/or a Sulfonylurea

Sarah Thayer, Bhakti Arondekar, Carolyn Harley,

Annals of Pharmacotherapy

2010

47

A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes

Bijan J. Borah, Theodore Darkow, Jonathan Bouchard,

Clinical Therapeutics

2009

39

Adherence and Persistence Among Chronic Myeloid Leukemia Patients During Second-Line Tyrosine Kinase Inhibitor Treatment

Digisha Trivedi, Pamela Landsman‐Blumberg, Theodore Darkow,

Journal of Managed Care Pharmacy

2014

38

A Retrospective Analysis of Disability and Its Related Costs Among Employees With Chronic Obstructive Pulmonary Disease

Theodore Darkow, Pamela Kadlubek, Hemal Shah,

Journal of Occupational and Environmental Medicine

2007

32

Prevalence and cost of HIV-associated weight loss in a managed care population

Javeed Siddiqui, Amy Phillips, Eric S. Freedland,

Current Medical Research and Opinion

2009

26

Page 1